Toru Seo is a CEO and life sciences strategist with over two decades of experience spanning academia and the pharmaceutical industry, currently leading Lucidaim and Newsight Tech Angels from Tokyo. Trained as a pathologist with a PhD and a decade of research and teaching at institutions including Columbia University, he pivoted to industry leadership roles at Merck, MSD Banyu, Taisho, and Pfizer where he led external science, business development, and APAC strategic initiatives. He specializes in bridging scientific insight and corporate strategy to create disruptive drug discovery ecosystems and shepherd breakthrough therapies from concept to partnership. Known for coordinating global, multifunctional teams and managing complex external collaborations, he combines hands-on scientific credibility with executive-level portfolio and deal-making experience. An EMBA graduate focused on business operations and investment, he brings a rare blend of bench science rigor and commercial acumen that informs strategic decisions across R&D and licensing.
8 years of coding experience
3 years of employment as a software developer
EMBA, Business operation and Investment, EMBA, Business operation and Investment at Quantic School of Business and Technology
PhD, Pathology, PhD, Pathology at Wake Forest University School of Medicine
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.